 |
 |
 |
|
- Neprilysin /CD10 is a soluble biomarker for Heart Failure and cardiovascular research.
- Neprilysin is an enzyme that plays a role in breaking down amyloid-beta peptides in the brain. Amyloid-beta accumulation is a hallmark of Alzheimer’s disease, so NEP’s activity is significant in preventing or slowing the progression of this neurodegenerative condition.
- NEP is an enzyme that breaks down natriuretic peptides, which are involved in blood pressure regulation and fluid balance.
- Standard Range: 0.78 ~ 200 pg/mL
- Sensitivity: 0.3 pg/mL
- Calibration: rh Neprilysin-Fc Fusion (HEK293) or rh NEP (HEK293)
- Sample Type: Serum, Plasma
- Size: 96 T ($690), 192T ($1240) , 288T, 480T
- Luminescence Read on Top
- Online order with discount price
New Research:
- Eunhee Kim, et al. Irisin reduces amyloid-b by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron 111, 3619–3633, November 15, 2023
 - Neprilysin is an enzyme that plays a role in breaking down amyloid-beta peptides in the brain. Amyloid-beta accumulation is a hallmark of Alzheimer’s disease, so NEP’s activity is significant in preventing or slowing the progression of this neurodegenerative condition.
- NEP is an enzyme that breaks down natriuretic peptides, which are involved in blood pressure regulation and fluid balance.
|
|
|
 |
|
 |
|
|
|
 |
|
 |
|
Features
Size: 96 T Standard Range: 0.78 ~ 200 pg/mL Sensitivity: 0.3 pg/mL Sample Type: serum, EDTA plasma, Dilution Factor: 4 ~ 8 for serum or plasma Intra-CV: 4-6% Inter-CV: 4-9% Protocol: PDF
|
|
|
|
|
|
|